Latest close: a new 52-week lowSep 8, 2026what changed →
Is the price fair?
What SYK's price assumes
Stryker Corporation trades at 28.6× earnings against 30.9× for the median Medical Devices name, cheaper than its own group.
28.6
Trailing P/E · Medical Devices median 30.9 · cheaper than the typical name in its group
- Price / sales
- 5.03
Price / sales · as of 2026-Q1
- Free cash flow yield
- 3.9%
Free cash flow yield · Medical Devices median 3.9%
- Growth the price implies
- +8.9%
Growth the price implies · The price pays for +8.9% free cash flow growth a year for a decade; the business has delivered +25% a year over the last three.
Details›
- EV / EBIT2026-Q1
- 27.7
- EV / sales2026-Q1
- 5.47
- Healthcare median P/E362 names
- 29.9
- Medical Devices median P/E39 names
- 30.9
- Free cash flow, trailing twelve months
- $4.70B
- Market capitalisation
- $120.3B
- 3-year revenue growth
- +9.9%
- 3-year free cash flow growth
- +25%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $341.94 |
| Its own P/E history, median | $387.08 |
| Its own P/E history, upper quartile | $447.10 |
| 52-week range | $276.48 – $391.41 |
| Today | $276.48 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Devices
Ranks #10 of 29 by Smart Score